Showing results (21-30 of 34) with videos related to
Sort By:
Pageof 4
Plos One|October 30, 2013
Natural killer T cells in advanced melanoma patients treated with tremelimumabF Javier Ibarrondo, Otto O Yang, Thinle Chodon, et al.Cancer Discovery|November 23, 2013
A novel AKT1 mutant amplifies an adaptive melanoma response to BRAF inhibitionHubing Shi, Aayoung Hong, Xiangju Kong, et al.Nature|November 26, 2010
Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulationRamin Nazarian, Hubing Shi, Qi Wang, et al.Cancer Discovery|March 23, 2013
Multifunctional T-cell analyses to study response and progression in adoptive cell transfer immunotherapyChao Ma, Ann F Cheung, Thinle Chodon, et al.Cancer Immunology Research|January 21, 2016
PD-1 Blockade Expands Intratumoral Memory T CellsAntoni Ribas, Daniel Sanghoon Shin, Jesse Zaretsky, et al.Nature Communications|March 8, 2012
Melanoma whole-exome sequencing identifies (V600E)B-RAF amplification-mediated acquired B-RAF inhibitor resistanceHubing Shi, Gatien Moriceau, Xiangju Kong, et al.Journal for Immunotherapy of Cancer|March 25, 2025
mTOR inhibition modulates vaccine-induced immune responses to generate memory T cells in patients with solid tumorsHenry G Withers, Junko Matsuzaki, Mark Long, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 14, 2020
A Phase I, Open-label, Dose-escalation, and Cohort Expansion Study to Evaluate the Safety and Immune Response to Autologous Dendritic Cells Transduced With AdGMCA9 (DC-AdGMCAIX) in Patients With Metastatic Renal Cell CarcinomaIzak Faiena, Begoña Comin-Anduix, Beata Berent-Maoz, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 5, 2013
Dendritic cell-based immunotherapy in prevention and treatment of renal cell carcinoma: efficacy, safety, and activity of Ad-GM·CAIX in immunocompetent mouse modelsFrédéric D Birkhäuser, Richard C Koya, Caleb Neufeld, et al.Cancer Discovery|November 23, 2013
Acquired resistance and clonal evolution in melanoma during BRAF inhibitor therapyHubing Shi, Willy Hugo, Xiangju Kong, et al.Pageof 4